NCT03624309 Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT03620123 A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT03611738 Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03607656 The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT03598595 Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03595059 A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT03588091 Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT03582475 Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03575013 A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer Status COMPLETED Phase PHASE1
NCT03574649 QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT03566576 Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel Status UNKNOWN Phase NA
NCT03517969 M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03505320 A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03497702 Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer Status UNKNOWN Phase PHASE2
NCT03493854 A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer Status COMPLETED Phase PHASE3
NCT03493425 Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery Status RECRUITING Phase PHASE2
NCT03486314 A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03474107 A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) Status COMPLETED Phase PHASE3
NCT03456843 Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03449901 ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer Status COMPLETED Phase PHASE2